Blisson
Did you know that nearly one in six people worldwide experiences infertility at some point in life? With rising concerns around PCOS, hormonal disorders, anemia, and pregnancy-related complications, the need for innovative, affordable, and reliable women’s healthcare solutions has never been greater. In this rapidly evolving and highly regulated sector, companies that combine quality, innovation, accessibility, and trust are making a meaningful difference.
One such company is Blisson, established in September 2019 to address critical gaps in women’s health, gynecology, and infertility care. Founded by Tushar Patil, Founder & CEIO, and Shripad Joshi, Vice President, both bringing over two decades of experience in gynecology, Blisson was built with a vision to develop innovative and accessible healthcare solutions. Despite being launched just before the COVID-19 pandemic, the company successfully navigated early challenges and steadily earned the trust of healthcare professionals across India.
Working closely with gynecologists and fertility specialists, Blisson identifies gaps in existing therapies and develops solutions using advanced technologies such as liposomal and nanoparticle-based formulations. Its portfolio spans fertility-enhancing nutraceuticals, maternal health products, and specialty therapies, with a focus on improving treatment outcomes while maintaining affordability and patient compliance.
In this exclusive interview for Prime Insights’ “India’s Most Trusted Gynecology & Infertility Product Manufacturers Advancing Women’s Health Solutions – 2026”, Tushar Patil and Shripad Joshi share Blisson’s journey, innovations, challenges, and vision for advancing women’s healthcare in India.
Prime Insights: For the benefit of our readers, could you introduce your company and its core product offerings in gynecology and infertility care?
Blisson has its name originated from “Continuous Bliss”, meaning “Continuous Complete Satisfaction…for Best of Health”.
We are committed towards Innovation, Quality, Reliability, Affordability, Trust & Consistency for the Gynaecological healthcare products, aiming to bless billions of patients and keep smiling for many years to come.
Journey began in Sept 2019,
The company identifies the gap and challenges in current therapies and tries to bridge the gap in Women’s Health, Gynaecology & Infertility.
The Gaps which are based on the cost of treatment, duration of treatment or shortfall in expected results in current therapies.
Prime Insights: What inspired the foundation of your company, and how has your journey evolved in the women’s healthcare sector?
Founders Tushar Patil (CEIO) & Shripad Joshi (Vice President) have an experience of 20+ years in gynaecology; Doctors are ready to share their therapy improvement expectations, and there is a technical backup to fulfil this expectation.
Today’s infertility treatment success outcome is still around 50%, a lot of scope to improve.
Lifestyle issues like PCOS are on the rise, and hormonal imbalance issues are causing disturbances in regular life.
Still, our maternal mortality rates are significantly more than those of the developed countries.
Various products were conceptualised, and with the feedback of the esteemed Gynaecologist and with the backing of the technical and medical team, we were able to fulfil these gaps.
Challenges like COVID were faced successfully just within 6 months of the launch, which helped to keep the morale of the employees high.
The Incentives based on performance have also ensured that the employees work to their best potential.
Prime Insights: What key challenges did you face in developing and manufacturing products in this highly sensitive and regulated domain?
We had clear ideas on how to overcome the regulatory challenges and did not take any shortcuts.
For a technical upgrade, our F&D unit helped by improvising the dissolution or developing nano-particle-based formulations.
We had done DCGI processes wherever it was necessary and then launched the products.
We verify all angles, including patent, plant technical capabilities, and storage requirements.
Prime Insights: How do you ensure the highest standards of quality, safety, and compliance in your manufacturing processes?
It basically begins with the plant standards, and we select the best of the plants which comply with the latest approved standards.
In case of improvement of results where we use nano technology, we have to go far beyond the approved Indian standards, and here we match/exceed the international brands or the Indian brand leader. We have an excellent F&D team to do these tasks.
Best manufacturing processes always ensure Quality, Safety and Compliance.
Prime Insights: What differentiates your products from others available in the gynaecology and infertility market?
We try to understand the gaps between expectations and therapies. Infertility treatment success gaps can be bridged with improvement in Quality/drug delivery technique.
We put the best quality raw material in our fertility-enhancing nutraceutical products.
In some cases, we have provided the monthly therapy at a particular cost point to improve cost-related treatment compliance.
In the case of our Iron & Calcium preparations, we have improved compliance by improving the patient tolerance, thus the success rates.
Prime Insights: How do research, innovation, and technological advancements contribute to your product development pipeline?
Once we identify the gap in a therapy, we start working towards the solution.
We start by identifying technological gaps, if any, and also explore newer drug delivery systems like nanonisation or Liposomal.
Once we identify the solution, our F & D team takes over to match the exact requirements.
Once the formulation is stabilised in the lab, it goes for production as per our required preset standards.
Prime Insights: Can you highlight any flagship products or breakthrough solutions that have significantly impacted women’s health?
Our flagship product is Beritol grp, where we have done 2 breakthrough solutions. Berberine has an active ingredient Berberine HCL, we have got berberine Purified to the extent 98% berberine HCL. To improve the bioavailability, we have improved the purified Berberine as Liposomal format, improving the bioavailability by 4 times.
This innovation has increased the success rate & becoming a favourite product of the speciality.
We are the first company to produce Carbetocin in India (Brand name Carbecin), which is the most accepted product in PPH.
Inj i3 is another breakthrough in injectable iron for the fastest haemoglobin rise with no side effects, ensuring significant haemoglobin rise in anaemia patients.
Prime Insights: How do you stay aligned with evolving medical guidelines, patient needs, and global healthcare standards?
We are in a relationship with various Gynec bodies like Gestosis, ICOG, FOGSI and many senior Physicians in the Gynec segment. They guide us on our planned solutions.
We explore various international bodies, ACOG, FIGO, for international trends and past clinical data is helpful.
For Innovative and first time in India, we adopted the DCGI route. All our claims are backed by clinical data and approved by medical affairs.
Prime Insights: What role do partnerships with healthcare providers, hospitals, or fertility clinics play in your growth?
Today, health care providers, hospitals, and fertility clinics have plenty of choices; it is essential to ensure their trust in our claimed quality and results.
We regularly conduct CME programs by reputed Senior Gynec Physicians. We also run small knowledge upgrade programs in medical colleges for Gynaecology students.
We also provide 5 patients with complete therapy to physicians for free to form their own opinion based on their experiences.
Prime Insights: How do you address affordability and accessibility to ensure your solutions reach a wider patient base?
Wherever the feedback is about the prohibitive monthly cost of existing therapies, we provide the same therapy at an economical price.
We have kept our products at the most affordable price compared to similar products.
However, Gynaecological problems involve a lot of pain, anxiety, and emotions. We need to look at the cost of a failed cycle while treating infertility. When we look at hormonal imbalances, we need to look at the cost of the days lost. In Nutraceutical needs during pregnancy, the cost must be judged by way of labour room mishaps and the health of the baby. It is a balance of our cost of therapy vs the cost of failed therapy.
Prime Insights: What milestones or achievements best represent your company’s credibility and trust in the market?
In less than 5th year of launch, we have almost 10000+ gynaecologists in India who are using our products & now the count is increasing significantly.
All leading gynaecologists & Key Opinion Leaders of India know about Blisson & Products.
Prime Insights: How do you ensure ethical practices and transparency in product development and distribution?
We have SOP in all processes right up to the product being handed over to the retailers, and these SOP begin right from the selection of the product, F&D development, to manufacturing plants, storage in Depots. The ERP system used flags the deviation, if any.
Prime Insights: What strategies have helped you build a strong brand presence and trust among healthcare professionals?
Consistent ethical promotion, strong conviction of our products through product knowledge and motivated field staff. High quality with continuation of dissipation of product benefits through CMEs and field staff visits.
Prime Insights: What are your future plans, innovations, or expansion strategies for advancing women’s health solutions?
Strengthen the strength, our strength is gynaecology, and there is plenty of opportunity there. We have plans to grow geographically in the remaining parts of India and add to our field force for penetration. As done earlier, we will keep on exploring the gaps to improve the fertility treatment outcomes, maternal health, and women’s health. Unexplored areas like menopause and the OC pill can be explored. We will always remain a quality-conscious, ethical company which will work in the long run.
Prime Insights: Finally, what message would you like to share with healthcare professionals, patients, and aspiring entrepreneurs about contributing to women’s health and well-being?
There are plenty of things which can be done consistently in women’s health, and alone, Blisson may not be able to do everything. Work for improving women’s health with high-quality products. Ensure quality, ethics and compliance with the regulatory requirements; there is plenty of opportunity. Many more hands will be needed to fulfil India’s dream of zero maternal mortality and good health for the women of the 21st century.
